Research ArticleNEUROSCIENCE

Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease

See allHide authors and affiliations

Science Advances  20 Mar 2019:
Vol. 5, no. 3, eaav0316
DOI: 10.1126/sciadv.aav0316
PDF Container

Navigate This Article